SCHEMBL18369826

SCHEMBL18369826

Cc1ccc(Nc2cc3c(cn2)N(C)C(=O)c2ccccc2N3C)c(C)c1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPK7 Q13164 6/20 0.54
▸ BRD4 O60885 6/20 0.54
▸ PIK3CD O00329 2/20 0.51
▸ AURKA O14965 2/20 0.51
▸ PIK3C2G O75747 2/20 0.51
▸ PIK3CG P48736 2/20 0.51
▸ AURKB Q96GD4 2/20 0.51
▸ KCNH2 Q12809 1/20 0.48
▸ DCLK1 O15075 5/20 0.47
▸ LRRK2 Q5S007 4/20 0.47
▸ PIK3CA P42336 1/20 0.44
▸ MTOR P42345 1/20 0.44
▸ PRKDC P78527 1/20 0.44
▸ MAPK1 P28482 1/20 0.42
▸ RAB9A P51151 2/20 0.41
▸ TNK2 Q07912 2/20 0.41
▸ HPGD P15428 1/20 0.40
▸ MEN1 O00255 1/20 0.40
▸ KMT2A Q03164 1/20 0.40
▸ NPC1 O15118 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18369886 0.90 MAPK7 (0.57) MAPK7BRD4PIK3CDAURKAPIK3C2G
SCHEMBL18369863 0.89 MAPK7 (0.55) MAPK7BRD4PIK3CDAURKAPIK3C2G
SCHEMBL17059912 0.88 MAPK7 (0.52) MAPK7BRD4PIK3CDAURKAPIK3C2G
SCHEMBL18369869 0.87 PRKDC (0.53) MAPK7BRD4PIK3CDAURKAPIK3C2G
SCHEMBL17059908 0.86 MAPK7 (0.52) MAPK7BRD4PIK3CDAURKAPIK3C2G
SCHEMBL18369922 0.86 MAPK7 (0.50) MAPK7BRD4PIK3CDAURKAPIK3C2G
SCHEMBL18369927 0.86 MAPK7 (0.62) MAPK7BRD4PIK3CDAURKAPIK3C2G
SCHEMBL18369946 0.85 MAPK7 (0.51) MAPK7BRD4PIK3CDAURKAPIK3C2G
SCHEMBL18370084 0.85 MAPK7 (0.51) MAPK7BRD4PIK3CDAURKAPIK3C2G
SCHEMBL18369799 0.82 MAPK7 (0.51) MAPK7BRD4PIK3CDAURKAPIK3C2G

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170008888-A1 HETEROCYCLIC COMPOUNDS ACTIVX BIOSCIENCES, INC. 2017-01-12 — — US disclosed
US-20170008888-A1 HETEROCYCLIC COMPOUNDS ACTIVX BIOSCIENCES, INC. 2017-01-12 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170008888-A1 HETEROCYCLIC COMPOUNDS BET1, EP300, RBBP5 MAPK7 58/4885BRD4 4/4885PIK3CD 1035/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback